Myomectomy Revisited: Experiences in a Teaching Hospital
DOI:
https://doi.org/10.31729/jnma.2823Keywords:
abnormal uterine bleeding; degeneration; myomectomy.Abstract
Introduction: Uterine myomas are the most common benign tumors of the female reproductive tract with myomectomy being one of the major modalities of the treatment in our set up. The aim of this study was to share the experiences of open myomectomy from a Teaching Hospital.
Methods: A observational study was conducted from a records of myomectomy cases in the department of Obstetrics and Gynaecology at Nobel Medical College teaching Hospital from June 2014- May 2016.
Results: Total 38 cases of myomectomy were performed during the study period in the women most commong age group being 35-39 years, followed by 30-34. The most common presenting symptoms was abnormal uterine bleeding in 15 (39.47%) followed by mass per abdomen in 10 (26.31%). The most common location of the myoma was intramural followed by subserosal, submucus. Degeneration was also noted in majority of the cases. All the myomectomies were done with Inj Vasopressin injected paracervically except in one case where tourniquet was used. None of the patients had significant post-operative morbidity except fever in the first 24 hours.
Conclusions: Abdominal myomectomy is a safe and effective procedure for uterine myomas for infertile women in the past but it should be offered to those desiring for uterine preservation irrespective of age and reproductive status.
Keywords: abnormal uterine bleeding; degeneration; myomectomy. | PubMed
References
symptomatology, and management. Fertil Steril. 1981;
36(4):433–45.
2. Chen I, Lisonkova S, Joseph KS, Williams C, Yong P, et al.
Laparoscopic versus abdominal myomectomy: practice
patterns and health care use in British Columbia. J Obstet
Gynaecol Can. 2014;36:817-21.
3. Myers ER, Barber ND. Management of uterine leiomyomata:
What do we really know? Am J Obstet Gynecol. 2002;100:8-17.
4. Farquhar C, Brown PM, Furness S. Cost effectiveness of
pre- operative gonadotrophin releasing analogues for
women with uterinefibroids undergoing hysterectomy or
myomectomy. BR J Obstet Gynecol. 2003;110:712-3.
5. Roth TM, Gustilo-Ashby T. Effects of race and clinical factors
on short –term outcomes of abdominal myomectomy. Am. J
Obst Gynecol. 2003;101:881-4.
6. Aboyeji, AP, Ijaiya MA. Uterine fibroids: A ten year clinical
review in IIorin, Nigeria. Niger J Med. 2002;11(1):16-9.
7. Omu AE, ihejerica IJ, Tabowei G. Management f uterine
fibroids at the University of Benin Teaching Hospital. Trp
Doct. 1984;14(2):82-5.
8. Radosa MP, Winzer H, Mothes AR, Camara O, Diebolder H,
Weisheit A et al. Laparoscopic myomectomy in peri-and post
–menopausal women is safe and efficacious and associated
with long term patient satisfaction. Eur J Obstet Gynecol
Reprod Biol.2012;162(2 ):192-6.
9. Hanafi M. Predictors of leiomyoma recurrence after
myomectomy. Obstet gynecol 2005;105(4):877-81.
10. Frederick J, Fletcher H, Simeon D, Mullings A, Hardie M.
Intramyometrial vasopressin as a hemostatic agent during
myomectomy. Br J Obstet Gynecol. 1994;101:435-7.
11. Sizzi O, Rossetti a, MalzoniM, Minelli L, La Grotta f,
SorannaL et al. Italian multicenter study on complications
of laparoscopic myomectomies. J Minim Invasive Gynecol.
2007;14:453-62.
12. Soriano D, Dessolle L, Poncelet C, Benefia JL, Madelenet
P, darai E. Pregnancy outcome after laparoscopic and
lapro converted myomectomy. Eur J Obstet Gynecol.
2003;108:194-8.
Downloads
Published
How to Cite
Issue
Section
License
JNMA allow to read, download, copy, distribute, print, search, or link to the full texts of its articles and allow readers to use them for any other lawful purpose. The author(s) are allowed to retain publishing rights without restrictions. The JNMA work is licensed under a Creative Commons Attribution 4.0 International License. More about Copyright Policy.
